B72.3
Jump to navigation
Jump to search
| B72.3 | |
|---|---|
| Immunostain in short | |
| Use | mesothelioma versus carcinoma |
| Normal staining pattern | cytoplasmic |
| Positive | most carcinomas |
| Negative | malignant mesothelioma |
B72.3 in an immunostain useful in the diagnosis of malignant mesothelioma.[1]
Use
Negative
- Mesothelioma - stains ~3% (6 of 196[1]).
Positive
- Most carcinomas.[2]
See also
References
- ↑ 1.0 1.1 Tandon, RT.; Jimenez-Cortez, Y.; Taub, R.; Borczuk, AC. (Feb 2018). "Immunohistochemistry in Peritoneal Mesothelioma: A Single-Center Experience of 244 Cases.". Arch Pathol Lab Med 142 (2): 236-242. doi:10.5858/arpa.2017-0092-OA. PMID 29048219.
- ↑ Betta, PG.; Pavesi, M.; Pastormerlo, M.; Tallarida, F.; Bellingeri, D.; Bocca, R.. "Use of monoclonal antibody B72.3 as a marker of metastatic carcinoma cells in neoplastic effusions.". Pathologica 83 (1083): 99-104. PMID 1866206.